secwatch.observer — SEC 8-K summary
======================================

Issuer:     TALPHERA, INC. (TLPH)
CIK:        0001427925
Form:       8-K
Filed at:   2022-12-29T23:59:59+00:00
Accession:  0001437749-22-029857
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AcelRx raises ~$7.5M via registered direct offering of common stock and warrants
--------------------------------------------------------------------------------

- Sold 748,744 shares, pre-funded warrants for 2,632,898 shares, and common warrants for 4,227,052 shares at $2.22625 combined price.
- Gross proceeds ~$7.5M; Cantor Fitzgerald placement agent with 7% fee.
- Common warrants exercisable at $2.07 after 6 months, 6-year term, full ratchet anti-dilution with $1.00 floor.
- Amended prior warrant held by purchaser to reduce exercise price to $2.07.
- Closing expected on or about Dec 29, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427925/000143774922029857/0001437749-22-029857-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427925/000143774922029857/acrx20221227_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-029857

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer